Advertisement

Topics

Note rounds nab $100M for Stealth

06:09 EDT 19 Jun 2018 | SmartBrief

Stealth BioTherapeutics intends to use the $100 million raised from two convertible note rounds to launch a Phase IIb study o -More

Original Article: Note rounds nab $100M for Stealth

NEXT ARTICLE

More From BioPortfolio on "Note rounds nab $100M for Stealth"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology Products
BioPortfolio lists over 550 biotechnology products - please open http://www.bioportfolio.com/channels?category_id=5 Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...